Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.
暂无分享,去创建一个
D. Finkelstein | A. Muzikansky | S. Thayer | A. Warshaw | C. Ferrone | C. Fernandez-delCastillo | C. Fernández-delCastillo
[1] N. Scarmeas,et al. CA 19-9 levels predict results of staging laparoscopy in pancreatic cancer , 2005, Journal of Gastrointestinal Surgery.
[2] B. Eisenberg,et al. Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas , 1997, Annals of Surgical Oncology.
[3] I. Meszoely,et al. Undetectable Preoperative Levels of Serum CA 19-9 Correlate with Improved Survival for Patients with Resectable Pancreatic Adenocarcinoma , 2004, Annals of Surgical Oncology.
[4] Diethelm Wallwiener,et al. Authors' Disclosures of Potential Conflicts of Interest The authors indicated no potential conflicts of interest. , 2004 .
[5] R. Bold,et al. Utility of tumor markers in determining resectability of pancreatic cancer. , 2003, Archives of surgery.
[6] N. Willich,et al. CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy. , 2003, Anticancer research.
[7] V. Heinemann,et al. CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin. , 1999, Anticancer Research.
[8] J. Rhodes. Usefulness of novel tumour markers. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] S. Nomoto,et al. Clinical usefulness of CA-19-9 in pancreatic carcinoma. , 1998, Seminars in surgical oncology.
[10] W. Schlosser,et al. Prognostic value of CA 19-9 serum course in pancreatic cancer. , 1998, Hepato-gastroenterology.
[11] H. Gogas,et al. Are serial measurements of CA19-9 useful in predicting response to chemotherapy in patients with inoperable adenocarcinoma of the pancreas? , 1998, British Journal of Cancer.
[12] H. Koprowski,et al. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. , 1983, Cancer research.
[13] V. Zurawski,et al. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. , 1983, Clinical chemistry.
[14] M. Herlyn,et al. Specific antigen in serum of patients with colon carcinoma. , 1981, Science.
[15] M. Herlyn,et al. Colorectal carcinoma antigens detected by hybridoma antibodies , 1979, Somatic cell genetics.
[16] D.,et al. Regression Models and Life-Tables , 2022 .